In Memoriam of the 4CC Co-Founder, Professor Henry Krum
Professor Henry Krum, the co-founder of the 4 Corners of Cardiology Meeting, passed away on Saturday 28th November 2015. Henry was an internationally renowned researcher, teacher and mentor who has helped shape our thinking, right through from basic cardiovascular physiology to large international clinical trials.
Prof Henry Krum
Prof Henry Krum was a recognised leader in cardiovascular therapeutics, particularly in the area of novel cardiovascular drug therapies. This is attested to by his publication record, grant success and invitations to give plenary talks at major international meetings. He was the Editor-in-Chief, Associate Editor and/or Editorial Board member of many international cardiovascular therapeutics journals and former President of the Asian Pacific Society of Heart Failure. Prof Krum had been Chairman and Executive Committee member of numerous international clinical trials as well as serving on Endpoint Committees and DSMBs for such trials. He was appointed Study Chairman of a 7000 patient global heart failure trial. He has in addition, led many investigator-initiated trials of cardiovascular therapeutic agents.
The members of the 5th International 4 Corners of Cardiology 2020 Organising Committee are:
Prof Clara Chow
Professor of Medicine, Academic Director Westmead Applied Research Centre
Dr. Clara Chow is Professor at Sydney Medical School, Westmead. She is Academic Director of the Westmead Applied Research Centre (WARC) and Program Director Community Based Cardiac Services and Cardiologist at Westmead hospital. She is appointed as the CPC (Charles Perkins Centre) Westmead Academic Co-director. Currently she is Treasurer of the Cardiac Society of Australia and New Zealand and Co-chair of the Secondary Prevention Alliance in Australia. She has a PhD from the University of Sydney, Australia in cardiovascular epidemiology and international public Health and a Postdoc from McMaster University, Canada in clinical trials and cardiac imaging. She is a NHMRC / National Heart Foundation Career Development Fellow. The main focus of her research is in simple and scalable approaches to cardiovascular disease prevention.
Prof John French
John’s major clinical research focus has been in the acute coronary syndromes, particularly on the assessment of myocardial reperfusion assessed by infarct-related artery blood flow, ST recovery, left ventricular function, and late clinical outcomes in patients with ST elevation myocardial infarction. He has been an active researcher having been an investigator and co-investigator in numerous randomised controlled trials and clinical trials and was on the writing committee of the HERO-2 trial. John was on the steering committee for the SHOCK, OAT and HERO-2 trials and he was the chair of the myocardial infarction adjudication committee and ECG sub-study for HERO-2. As part of a continuing interest in molecular medicine John has established the cardiac genetics clinics with the genetics department, and is a member of TRAGADY. John has co-authored >120 peer-reviewed publications and six book chapters. He has supervised a number of MD and MHSc postgraduate students and has been invited speaker at recent American College and American Heart Association meetings.
Prof David Kaye
Professor David Kaye is Director of the Department of Cardiology at the Alfred Hospital and a senior member the Advanced Heart Failure Service. He leads the Cardiology Research Program at the Baker Heart and Diabetes Institute. David’s research work has been directed towards better understanding the causes of heart failure and in developing new treatments. Several of his discoveries have been clinically translated, with the establishment of 3 clinically active early to mid-stage companies. Professor Kaye holds numerous grants in support of his research.
A/Prof Saurabh Kumar
I am a Cardiologist, Cardiac Electrophysiologist, Staff Specialist, Program Director for Ventricular Arrhythmias and Sudden Cardiac Death at Westmead Hospital, Clinical Associate Professor of Medicine, Sydney Medical School, University of Sydney, Principal Investigator at Westmead Applied Research Centre, Chair of the Heart Rhythm Council Cardiac Society of Australia and New Zealand the NSW Health Early-Mid Career Fellow. I have received excellent clinical and academic training in cardiac electrophysiology at 2 prestigious institutions. At Royal Melbourne Hospital (Uni. Melb; 2010-2013), I completed a 3.5 yr clinical fellowship/PhD under the supervision of Prof. Jonathan Kalman, providing important contributions on the mechanisms of human atrial fibrillation. At the Brigham & Women’s Hospital (Harvard Medical School) for 3.5 yrs (2013-2016), I did a post-doctoral fellowship with Prof. William Stevenson making seminal contributions to the mechanism and treatment of ventricular arrhythmias and sudden cardiac arrest, providing the necessary clinical and academic skills, training and collaborations for the current proposal.
Prof Christopher Reid
Christopher Reid is a cardiovascular epidemiologist with appointments as Research Professor in both the School of Public Health at Curtin University and the School of Public Health and Preventive Medicine, Monash University. He was appointed as a John Curtin Distinguished Professor in 2018 and is Director of the Monash and Curtin Centre’s of Cardiovascular Research and Education (CCRE) and the NHMRC Centre of Research Excellence in Cardiovascular Outcomes Improvement (2016-2020). He holds a National Health and Medical Research Council Principal Research Fellowship (2018-2022) in addition to being the Chief Investigator on an NHMRC Program Grant (2016-2020) focusing on cardiovascular disease prevention. He has been awarded over $113M as a Chief Investigator and has received continuous NHMRC funding since 2001. His major research interests include clinical outcome registries, randomized controlled trials, and epidemiological cohort studies. He has over 420 peer-reviewed publications, many of which are in leading journals including the New England Journal of Medicine, Lancet, JACC and the BMJ. He has been Study Director for the 2nd Australian National Blood Pressure (ANBP2) Study and currently a Chief Investigator for the Aspirin in Reducing Events in the Elderly (ASPREE) Study, the Statins in Reducing Events in the elderly Trial and the Australian arms of the HOPE-3, REACH and CLARIFY Registries. He is a Principal Investigator for the Victorian Cardiac Procedures Registry Project, the Melbourne Interventional Group (MIG) registry, and the ANZSCTS National Cardiac Surgical Registry. He participates as a WHO consultant for prevention of cardiovascular disease in Mongolia, Vietnam and the West Pacific region.
Prof Andrew Tonkin OAM
Prof Andrew Tonkin OAM is Head, Cardiovascular Research Unit, Department of Epidemiology and Preventive Medicine, Monash University. Previously he has been Director of Cardiology at Austin Health, Melbourne and Flinders Medical Centre, Adelaide and Chief Medical Officer of the National Heart Foundation.
Professor Tonkin has been a member of the Executive Board of the Council on Clinical Cardiology of the World Heart Federation and chaired many national expert groups developing clinical guidelines for cardiovascular disease, including lipid management. He was awarded an Order of Australia Medal for services to medical research and has twice been awarded the RT Hall Prize, the major research award of the Cardiac Society of Australia and New Zealand, and the Sir John Loewenthal Award, the major award of the Heart Foundation. He has over 400 publications.